Virax Biolabs Group Ltd (VRAX) Operating income 2021–2025
Virax Biolabs Group Ltd (VRAX) annual operating income history from SEC filings — each fiscal year as reported.
-$6.2MFY2025 · since FY2021: -$644,538 → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | +5.1% |
| FY2024 | -$6.5M | -13.3% |
| FY2023 | -$5.7M | -230.7% |
| FY2022 | -$1.7M | -169.0% |
| FY2021 | -$644,538 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX RevenueVRAX Net incomeVRAX Net marginVRAX Gross profitVRAX Gross marginVRAX Operating marginVRAX Operating cash flowVRAX Free cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Total liabilitiesVRAX Shareholders’ equityVRAX overview →